Weikang Bio-Technology Group Co., Inc.

Weikang Bio-Technology Group Co., Inc. – Amendment to Make Good Securities Escrow Agreement (December 29th, 2010)

THIS AMENDMENT dated as of December 22, 2010 ("Amendment"), is by and among Weikang Bio-Technology Group Company, Inc., a Nevada corporation (the "Company"), Lucky Wheel Limited (the "Principal Shareholder"), a British Virgin Islands corporation, and Sichenzia Ross Friedman Ference LLP with an address at 61 Broadway, 32nd Floor, New York, NY 10006 (the "Escrow Agent").

Weikang Bio-Technology Group Co., Inc. – Lock-Up Agreement (December 8th, 2010)

THIS AGREEMENT (this "Agreement") is dated as of December 2, 2010 by and between Weikang Bio-Technology Group Company, Inc., a Nevada corporation (the "Company"), and ____________ ("Shareholder").

Weikang Bio-Technology Group Co., Inc. – Make Good Securities Escrow Agreement (December 8th, 2010)

THIS MAKE GOOD SECURITIES ESCROW AGREEMENT (the "Make Good Agreement" or the "Agreement"), dated as of December 2, 2010, is entered into by and among Weikang Bio-Technology Group Company, Inc., a Nevada corporation (the "Company"), Lucky Wheel Limited (the "Principal Shareholder") and Sichenzia Ross Friedman Ference LLP with an address at 61 Broadway, 32nd Floor, New York, NY 10006 (the "Escrow Agent").

Weikang Bio-Technology Group Co., Inc. – Weikang Bio-Technology Group Company, Inc. Series D Warrant to Purchase Shares of Common Stock (December 8th, 2010)

This Warrant is being issued pursuant to a Confidential Private Placement Memorandum dated November 5, 2010, as supplemented thereto (the "Confidential Private Placement Memorandum"), and a Subscription Agreement, dated December __, 2010 (the "Subscription Agreement"), by and between the Company and the Initial Holder, and is part of the Units described in the Subscription Agreement.

Weikang Bio-Technology Group Co., Inc. – Weikang Bio-Technology Group Company, Inc. Warrant to Purchase Shares of Common Stock (December 8th, 2010)

This Warrant is being issued pursuant to an engagement letter, dated September 30, 2010, by and between the Company and the Initial Holder (the "Engagement Letter").

Weikang Bio-Technology Group Co., Inc. – Investor and Public Relations Escrow Agreement (December 8th, 2010)

This Agreement, dated as of December 2, 2010 (this "Agreement"), is entered into by and among Weikang Bio-Technology Group Company, Inc., a Nevada corporation (the "Company"), Sichenzia Ross Friedman Ference LLP (the "Escrow Agent"), and MidSouth Investor Fund LP, as representative for the Subscribers in that certain Subscription Agreement (as defined herein) ("Subscriber Representative) (the Company and the Subscriber Representative are collectively referred to as "Escrowing Parties").

Weikang Bio-Technology Group Co., Inc. – Escrow Deposit Agreement (December 8th, 2010)

This ESCROW DEPOSIT AGREEMENT (this "Agreement") dated as of this 25th day of October, 2010, by and among Weikang Bio-Technology Group Company, Inc., a Nevada corporation (the "Company"), having an address at No. 365 Chengde Street, Daowai District, Harbin Heilongjiang Province, The People's Republic of China 150020, Hunter Wise Securities, LLC, a California limited liability company ("Placement Agent"), having an address at 2361 Campus Drive, Suite 100, Irvine, CA 92612, and SIGNATURE BANK (the "Escrow Agent"), a New York State chartered bank, having an office at 950 Third Avenue, 9th Floor, New York, NY 10022. All capitalized terms not herein defined shall have the meaning ascribed to them in that certain Confidential Private Placement Memorandum, dated October 25. 2010 as amended or supplemented from time-to-time, including all attachments, schedules and exhibits thereto (the "Memorandum").

Weikang Bio-Technology Group Co., Inc. – Registration Rights Agreement (December 8th, 2010)

This Agreement is made pursuant to separate Subscription Agreements, dated as of the date hereof, between the Company and each Purchaser (the "Subscription Agreements").

Weikang Bio-Technology Group Co., Inc. – Weikang Bio-Technology Group Company, Inc. Series C Warrant to Purchase Shares of Common Stock (December 8th, 2010)

This Warrant is being issued pursuant to a Confidential Private Placement Memorandum dated November 5, 2010, as supplemented thereto (the "Confidential Private Placement Memorandum"), and a Subscription Agreement, dated December __, 2010 (the "Subscription Agreement"), by and between the Company and the Initial Holder, and is part of the Units described in the Subscription Agreement.

Weikang Bio-Technology Group Co., Inc. – CALL OPTION AGREEMENT BETWEEN WANG, WEI LI AND Individual Listed in Schedule a Fu Jian ASuo Lie Ge Ren Date: May 5, 2010 (August 10th, 2010)

THIS CALL OPTION AGREEMENT (this "Agreement") is made on May 5, 2010 by and between WANG, WEI LI, a US passport holder, (the "Grantor"), and the individual listed in Schedule A (the "Grantee").

Weikang Bio-Technology Group Co., Inc. – Settlement Agreement and Release (August 10th, 2010)

This Settlement Agreement and Release ("Agreement") is entered into this 6th day of August, 2010 (the "Effective Date") by and among Sinary Bio-Technology Holdings Group, Inc. ("Sinary") on the one hand, and Yin Wang and Wei Wang (together with Yin Wang, the "Sellers"), on the other hand. Sinary and the Sellers will be referred to collectively in this Agreement as the "Parties."

Weikang Bio-Technology Group Co., Inc. – Charter of the Compensation Committee of the Board of Directors of Weikang Bio- Technology Group Co., Inc. Adopted as of April __, 2010 (April 21st, 2010)

The Compensation Committee's responsibilities and powers as delegated by the board of directors are set forth in this Charter. Whenever the Committee takes an action, it shall exercise its independent judgment on an informed basis that the action is in the best interests of the Company and its stockholders.

Weikang Bio-Technology Group Co., Inc. – Charter of the Nominating and Corporate Governance Committee of the Board of Directors of Weikang Bio-Technology Group Co., Inc. Adopted as of April __, 2010 (April 21st, 2010)

The Nominating and corporate Governance Committee's responsibilities and powers as delegated by the board of directors are set forth in this Charter. Whenever the Committee takes an action, it shall exercise its independent judgment on an informed basis that the action is in the best interests of the Company and its stockholders.

Weikang Bio-Technology Group Co., Inc. – Land Use Right Cert Owner Address Meters Tianfang (Guizhou)Pharmaceutical Inc., Zhenzhu Jingpian Area,Zhazuo Town,Xiuwen County, 71907.03 Square Meter Real Estate Cert Owner Address Meters Tianfang (Guizhou)Pharmaceutical Inc., Zhenzhu Jingpian Area, Zhazuo Town,Xiuwen County, 188.7 Square Meter Tianfang (Guizhou)Pharmaceutical Inc., Zhenzhu Jingpian Area, Zhazuo Town,Xiuwen County, 116.61 Square Meter Tianfang (Guizhou)Pharmaceutical Inc., Zhenzhu Jingpian Area, Zhazuo Town,Xiuwen County, 27.85 Square Meter Tianfang (Guizhou)Pharmaceutical Inc., Zhenzhu Jingpian Area, Zhazuo Town,Xiuwen Count (March 25th, 2010)

Weikang Bio-Technology Group Co., Inc. – Lease Agreement (March 25th, 2010)

This agreement is entered into this day of January 1, 2008, by and between Heilongjiang Weikang Bio-technology Group Company Inc. ("Party A") and Harbin Dongfeng Pharmaceutical Corp., ltd ("Party B").

Weikang Bio-Technology Group Co., Inc. – Land Right Cert Owner Address Meters Heilongjiang Weikang Bio-Tech Group Economic Development Zone of Shuangcheng City 38988 Square Meter Real Estate Cert Heilongjiang Weikang Bio-Tech Group Economic Development Zone of Shuangcheng City 46.24 Square Meter Heilongjiang Weikang Bio-Tech Group Economic Development Zone of Shuangcheng City 2113.19 Square Meter Heilongjiang Weikang Bio-Tech Group Economic Development Zone of Shuangcheng City 46.24 Square Meter Heilongjiang Weikang Bio-Tech Group Economic Development Zone of Shuangcheng City 1951.04 Square Meter Heilongjiang Weikang Bio-Tech Group E (March 25th, 2010)

Weikang Bio-Technology Group Co., Inc. – Shell Company Purchase Agreement (March 25th, 2010)

THIS SHELL COMPANY PURCHASE AGREEMENT (this "Agreement"), is dated as of Dec.8, 2007, by and between Sinary Bio-Technology Holdings Group, Inc. (Party A) and Wangyin,CEO of Weikang (Party B)